Listening to the Frontlines: What the Diabetes Community Is Asking of Parliaments
January 28, 2026
Recently, we asked the diabetes community a few simple but powerful questions.
What is the biggest barrier to effective diabetes policy in your country? And if you could ask one thing of parliamentarians on diabetes in 2026, what would it be?
The responses were thoughtful, grounded, and deeply shaped by lived experience. Taken together, they tell a clear story: effective diabetes policy does not fail for lack of knowledge, but for lack of alignment with people’s real lives.
Affordability is not optional
Many voices came back to affordability as a defining issue. People spoke about the impossible choices families are forced to make between care and basic needs. Diabetes policy, they reminded us, should never place individuals in a position where survival depends on financial sacrifice. Affordability is not a technical detail. It is a moral baseline.
Access must go beyond availability
Access was described not just as having treatment on paper, but as timely, practical access to care and innovation. Community members highlighted delays in adopting new therapies, complex administrative barriers, and systems that move far more slowly than disease progression. When access lags, outcomes worsen. Policy needs to catch up to science.
Prevention starts with early and accurate diagnosis
Several contributions focused on prevention, particularly at the diagnostic stage. Missed or delayed diagnoses, especially in gestational diabetes, were described as quietly fuelling future disease burden. Prevention, the community stressed, is not about slogans or awareness days. It is about investing in accurate screening, early intervention, and long-term follow-up that actually works.
Data matters, but only if it is used
Calls for evidence-based decision-making surfaced repeatedly. Community members asked for better data collection, but also for accountability in how data informs policy choices. Data without follow-through becomes another missed opportunity. Strong governance and sustained follow-up were seen as just as important as generating evidence.
Nothing about us without us
Perhaps the strongest signal was around voice. The poll results and comments pointed clearly to one issue rising above the rest: the lack of meaningful patient involvement in policy design. People living with diabetes are not a stakeholder group to be consulted at the end. They are experts in how policy succeeds or fails in practice. When their voices are missing, policy loses relevance.
A message to the Parliaments
The community is not asking for miracles. It is asking for seriousness.
Serious investment in access and affordability. Serious prevention strategies rooted in early diagnosis. Serious use of data to guide decisions. And serious engagement with the people most affected. The choices made in parliaments shape how millions live with diabetes every day. Listening to lived experience is not a courtesy. It is a policy tool.
At PDGN, these conversations reinforce why community engagement sits at the heart of effective parliamentary leadership on diabetes. When policymakers listen closely, better policy follows.